A machine learning model found that background parenchymal enhancement (BPE) on breast MRI is an indicator of breast cancer risk in women with extremely dense breasts

Representative transverse dynamic contrast-enhanced MRI scans in patients in the low and high tertiles of volume of enhancing parenchyma. Please note differences in high and low volumes of enhancing parenchyma are not visible to the naked eye on MRI scans. Left: Baseline MRI scan in a 50-year-old woman with a body mass index (BMI) of 23 and marked background parenchymal enhancement (BPE) who was stratified into the high tertile of volume of enhancing parenchyma. Cancer was detected with MRI in the second screening round. Right: Baseline MRI scan in a 51-year-old woman with a BMI of 24 and marked BPE who was stratified into the low tertile of volume of enhancing parenchyma. No cancer was detected during 6 years of follow-up. Image courtesy of RSNA.Br 


August 9, 2023 — A machine learning model found that background parenchymal enhancement (BPE) on breast MRI is an indicator of breast cancer risk in women with extremely dense breasts, according to a study published in Radiology, a journal of the Radiological Society of North America (RSNA). 

Women with extremely dense breasts are at a three- to six-times higher risk of developing breast cancer compared to women who have fatty breasts. Since mammography is less sensitive in detecting early-stage breast cancer in women with dense breasts, women between the ages of 50 and 75 years with dense breasts may benefit from additional MRI screening

Another breast cancer risk factor is BPE, which is the level of normal fibroglandular tissue that enhances on breast MRI. However, not much is known about how BPE compares to other more established clinical risk factors of breast cancer, such as age, body mass index (BMI) family history, and breast density.  

“Thus far, studies on breast cancer risk factors have typically focused on women at high lifetime risk of developing breast cancer,” said study co-author Kenneth G. A. Gilhuijs, Ph.D., from the Department of Radiology at the University Medical Center Utrecht in the Netherlands. “This is the first study that we know of that demonstrates an association between background parenchymal enhancement and occurrence of breast cancer in women with extremely dense breasts.” 

To determine how much BPE is an indicator of breast cancer risk, the researchers used dynamic contrast-enhanced MRI exams from 4,553 participants in the Dense Tissue and Early Breast Neoplasm Screening (DENSE) Trial, a large multi-institutional study based in the Netherlands, to develop a deep learning model to automatically identify the fibroglandular tissue. The MRI exams were performed every two years in eight hospitals in the Netherlands between December 2011 and January 2016. 

After adjusting for age, BMI and BPE, the researchers found that breast cancer occurrence was greater in women with higher volumes of enhancing parenchyma compared to women with low volumes of enhancing parenchyma. 

Of the 4,553 women included in the study, 122 were diagnosed with breast cancer. Roughly 63% of them were diagnosed after the first round of screening. An average cancer detection time of 24 months was associated with the remaining women diagnosed with breast cancer.  

“Parenchyma does not enhance uniformly on MRI,” Dr. Gilhuijs said. “This method calculates all the different subvolumes at which the parenchyma enhances and sorts them from high to low.” 

The researchers point out that while the implementation of supplemental MRI screening in women with dense breasts will result in fewer interval cancers—which are breast cancers that are diagnosed in between routine mammography screenings—it will also further strain radiologist workloads. Developing more personalized strategies to deal with the added number of screenings may help alleviate the strain on the healthcare field. 

“Our study is a first step in a direction to further tailor the frequency of supplemental MRI screening to individual women with dense breasts, focusing not only on breast density as a main risk factor but also on other properties of the breast established from a first screening MRI,” Dr. Gilhuijs said. 

For more information: www.rsna.org 

Find more RSNA23 conference coverage here 

Related Breast Density Content:  

VIDEO: FDA Update on the US National Density Reporting Standard - A Discussion on the Final Rule  

One on One … with Wendie Berg, MD, PhD, FACR, FSBI  

Task Force Issues New Draft Recommendation Statement on Screening for Breast Cancer  

Creating Patient Equity: A Breast Density Legislative Update  

FDA Needs to Ensure that Information on Dense Breast Notifications are Clear and Understandable to all Members of the Public  

AI Provides Accurate Breast Density Classification  

VIDEO: The Impact of Breast Density Technology and Legislation  

VIDEO: Personalized Breast Screening and Breast Density  

VIDEO: Breast Cancer Awareness - Highlights of the NCoBC 2016 Conference  

Fake News: Having Dense Breast Tissue is No Big Deal  

The Manic World of Social Media and Breast Cancer: Gratitude and Grief  

Related Breast Imaging Content:  

Single vs. Multiple Architectural Distortion on Digital Breast Tomosynthesis  

Today's Mammography Advancements   

Digital Breast Tomosynthesis Spot Compression Clarifies Ambiguous Findings   

AI DBT Impact on Mammography Post-breast Therapy   

ImageCare Centers Unveils PINK Better Mammo Service Featuring Profound AI   

Radiologist Fatigue, Experience Affect Breast Imaging Call Backs   

Fewer Breast Cancer Cases Between Screening Rounds with 3-D Mammography  

Study Finds Racial Disparities in Access to New Mammography Technology  

American College of Radiology (ACR) Launches Contrast-Enhanced Mammography Imaging Screening Trial (CMIST) in Collaboration With GE Healthcare and the Breast Cancer Research Foundation 


Related Content

News | Radiology Business

July 17, 2023 — The Radiological Society of North America (RSNA) Research and Education (R&E) Foundation Board of ...

Time July 17, 2024
arrow
News | Flat Panel Displays

July 17, 2024 — LG Electronics (LG) is accelerating its B2B medical device business, expanding its lineup of diagnostic ...

Time July 17, 2024
arrow
News | Magnetic Resonance Imaging (MRI)

July 16, 2024 — Fujifilm Healthcare Americas Corporation, a leading provider of diagnostic and enterprise imaging ...

Time July 16, 2024
arrow
Videos | Radiology Business

Find actionable insights to achieve sustainability and savings in radiology in this newest of ITN’s “One on One” video ...

Time July 12, 2024
arrow
Feature | Imaging Technology News - ITN

Be sure to check out the latest digital edition of Imaging Technology News (ITN), featuring the Mobile C-arm Systems ...

Time July 11, 2024
arrow
News | Artificial Intelligence

July 11, 2024 — Artificial Intelligence (AI) tools can play a key role in medical imaging if radiologists trust in their ...

Time July 11, 2024
arrow
Feature | Radiology Business | By Christine Book

Across the healthcare industry, and, notably, throughout the radiology community in just the past few years, the focus ...

Time July 10, 2024
arrow
News | Artificial Intelligence

July 9, 2024 — Lunit, a provider of Artificial Intelligence (AI)-powered solutions for cancer diagnostics and ...

Time July 09, 2024
arrow
Feature | Computed Tomography (CT) | By Melinda Taschetta-Millane

In the ever-evolving landscape of medical imaging, computed tomography (CT) stands out as a cornerstone technology ...

Time July 08, 2024
arrow
Feature | Mobile C-Arms | By Melinda Taschetta-Millane

Mobile C-arms continue to revolutionize medical imaging, offering versatility, mobility and real-time visualization ...

Time July 08, 2024
arrow
Subscribe Now